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TECHNICAL NOTE
Antibodies to glomerular basement membrane: Detection by an
enzyme-linked immunosorbent assay in the sera
of Brown Norway rats
Jo H. MICHAELSON, J. PHILIP McCoy, JR., and PIERLuIGI E. BIGAzzI
Department of Pathology, University of Connecticut Health Center, Farmington, Connecticut
Circulating antibodies to the glomerular basement membrane
(GBM) of the kidney have been detected by indirect immunoflu-
orescence and, more recently, radioimmunoassays [1—41. Both
techniques present some disadvantages: indirect immunofluo-
rescence is of rather limited sensitivity and is dependent on a
subjective evaluation of fluorescence intensity, whereas radio-
immunoassays require radiolabeling of GBM, expensive radio-
activity counters, and are subject to increasing restrictions on
the handling and disposal of radioactive materials. In other
antigen-antibody systems, these disadvantages have been obvi-
ated by the introduction of an enzyme-linked immunosorbent
(or immunospecific) assay (ELISA), which maintains the sensi-
tivity of radioimmunoassays and uses safe and stable reagents
[51. For these reasons, we have investigated the use of ELISA
as an alternative procedure to detect circulating anti-GBM
antibodies. Prior to studies with human material and to make
sure of an adequate supply of sera and kidney eluates, we have
used the test to detect anti-GBM antibodies in sera from rats
treated with mercuric chloride. It has been shown that Brown
Norway (BN) rats injected with this chemical produce anti-
GBM antibodies that are deposited in a linear fashion in the
glomeruli of the kidney [6].
Methods
BN rats, obtained from Microbiological Associates (Walkers-
ville, Maryland) and Charles River Laboratories (Wilmington,
Massachusetts) were treated with mercuric chloride as previ-
ously described [6]. Direct immunofluorescence staining of the
kidneys from these rats and indirect immunofluorescence stain-
ing using sera from the same rats were performed by the method
of Sapin, Druet, and Druet [61. Antibodies bound to the
basement membranes of kidneys from BN rats treated with
mercuric chloride were eluted using low pH citrate buffer [7].
Alkaline-phosphatase-conjugated rabbit anti-rat immuno-
globulin was prepared according to the method of Engvall and
Perlmann [8] using commercially available alkaline phosphatase
(Sigma type VII, Sigma Chemical Co., St. Louis, Missouri) and
the DEAE-purified immunoglobulin fraction of a rabbit antise-
rum to rat immunoglobulin prepared in our laboratory. Micro-
titer plates of various brands and lot numbers were coated with
GBM prepared from pooled kidneys of normal BN, Buffalo, and
DA/L rats using a modification of a method previously de-
scribed [91 and solubilized with 8 M urea [3]. The protein
concentration of the soluble fraction of the urea-treated GBM,
as determined by the ratio of the absorbance at 280 nm to the
absorbance at 260 nm, indicated that 8.8% of the lyophilized
GBM was solubilized.
GBM was diluted to 10 g/ml in carbonate buffer (pH, 9.6),
and 100 p.l of this suspension were added to each well of a 96-
well microtiter plate. The plate was then incubated at 37° C for
3 hours and either used immediately or stored at 40 C. The
optimal concentration of GBM used routinely (10 g/ml) was
determined by checkerboard titration. Prior to the addition of
test sera, the coated plates were washed for 10 mm with three
washes of PBS (pH, 7.2) containing 0.05% Tween 20 (PBS-
Tween; Sigma Chemical Co., St. Louis, Missouri). After wash-
ing, rat sera to be tested were added to the wells. All sera were
examined in duplicate, using tenfold dilutions in PBS-Tween.
One hundred microliters of the sera were incubated in the well
of the microtiter plates for 30 mm at 37° C. The sera were then
removed from the plates, which were washed for 10 mm with
three changes of PBS-Tween. Following these washes, 100 iiof
alkaline-phosphatase-conjugated rabbit anti-rat immunoglob-
ulin, diluted 1:500 in PBS-Tween, were added to each well of
the microtiter plate. The optimal concentration of this conjugate
for routine use was initially determined by checkerboard titra-
tion. After an incubation of 30 mm at 37° C, the conjugated anti-
rat immunoglobulin was removed, and the plate washed for 10
mm with three changes of PBS-Tween. One hundred microliters
of a 1-mg/mI suspension of p-nitrophenyl phosphate (Phospha-
tase substrate, Sigma Chemical Co.) in carbonate buffer (pH,
9.6) were then added to each well. After a 45-mm incubation at
room temperature, the absorbance at 405 nm (OD405) was
determined in each well using a Titer-tek Multiskan (Flow
Laboratories, McLean, Virginia).
To inhibit the binding of rat anti-GBM antibodies to the
GBM-coated wells, 500 p.1 of a rat serum containing anti-GBM
antibodies were preincubated with 25 p.1 of a 1-mg/ml solution of
GBM. The incubation was conducted at 37° C for 2.5 hours,
with gentle agitation, in polystyrene tubes previously washed
three times with PBS-Tween. Controls consisted of 500 p.1
aliquots of the same serum preincubated with 25 p.l of 1-mg/mI
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Table 1. Results obtained by immunofluorescence and an enzyme-linked immunosorbent assay (ELISA) in mercuric chloride-treated and
control BN rats
Group Treatment
No. of
animals DIF IIFb
ELISA
Mean Range
Experimental
A HgCI2 9 + + 0.182 0.087to0.294
B HgCI2 lid + — 0.198 0.081 to 0.355
Control
C None 13 — — 0.033 0.013 to 0.065
D Distilled H20, pH 4.0 2 — — 0.045 0.030 to 0.060
E Saline 2 — — 0.028 0.016 to 0.039
DIF is direct immunofluorescence.
b hF is indirect immunofluorescence.
Mean value for undiluted sera.
d One serum in this group could not be tested undiluted by ELISA due to its limited quantity.
Fig. 1. A OD5 values of 17 sera samples
from untreated rats tested by ELISA for
anti-GBM antibodies. Broken line at 0.070
indicates designated OD5 above which a
reaction was considered positive. B OD5
values of sera from 20 mercuric-chloride-
treated rats tested by ELISA for ant j-GBM
antibodies. One serum was not tested undi-
luted.
rat thyroglobulin or with 25 pA of PBS. The sera were then
assayed for anti-GBM by ELISA as described above.
Results
Detection of antibodies to GBM by direct and indirect
immunofluorescence. Direct immunofluorescence on the kid-
neys obtained from treated rats 14 days after the first injection
of mercuric chloride revealed intense linear staining of the
GBM in 100% of these animals (Table 1). No such staining was
observed in kidney sections from untreated rats or control rats
injected with acidic distilled water alone or saline. When a scale
ranging from minus (—) (no fluorescence above background) to
4+ (extremely bright fluorescence) was used to provide a rough
quantitation of fluorescence intensity, the kidneys from mercu-
ric chloride-treated rats uniformly presented a 3 + or 4+ stain-
ing.
Indirect immunofluorescence proved insufficiently sensitive
to detect circulating antibodies to GBM, because 11 of 20 sera
from mercunc-chloride-treated rats did not stain the GBM
(Table 1). The remaining sera were weakly positive, and none of
them gave fluorescence staining over a 2+ intensity. Titers of
the positive sera ranged from 5 to 20.
Detection of antibodies to GBM by ELISA. As shown in
Table 1, a total of 37 BN sera were tested by ELISA, 20 of them
obtained from mercuric-chloride-treated rats and 17 from con-
trol animals. The highest 0D405 in the ELISA for any control
serum was 0.068 (Fig. 1A); therefore, the 0D405 of 0.070 was
chosen as the level above which any reading was considered
positive. Using this criterion, 19 out of 19 sera from mercuric-
chloride-treated rats, when tested undiluted, were positive for
anti-GBM antibodies (Fig. 1B). The 0D405 values of these sera
ranged from 0.081 to 0.355 with a mean of 0.190 and an SEM of
0.018. Thus, we were able to detect by ELISA circulating anti-
GBM in 100% of the sera from the experimental animals, as
compared with 45% by indirect immunofluorescence. When
sera were diluted tenfold, 70% of the mercuric-chloride-treated
animals remained positive for circulating anti-GBM although
the mean 0D405 for these sera dropped to 0.090 with an SEM of
0.007. Only 20% of the treated sera remained positive at a one-
hundredfold dilution and none were positive after being diluted
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Fig. 2. Inhibition
GBM.
1:1000. Titers of the sera containing anti-GBM antibodies
ranged from 5 to 700, most of them between 10 and 100. It
should be noted that sera from animals injected with acidic
distilled water or neutral saline were negative for anti-GBM
antibodies in indirect immunofluorescence and by ELISA.
Their kidneys were also negative by direct immunofluorescence
(Table 1).
Specificity of ELISA for anti-GBM antibodies. As may be
seen in Fig. 2, preincubation of anti-GBM serum with GBM
resulted in a substantial reduction of the anti-GBM activity in
the serum as detected by ELISA. Preincubation with rat
thyroglobulin produced only a slight reduction (6%) in the anti-
GBM activity, possibly due to some nonspecific binding to the
polystyrene tubes during the preincubation process. When
compared with the ELISA reactions of serum preincubated
with thyroglobulin or with PBS alone, the reaction of serum
preincubated with GBM was reduced by 81% and 82%, respec-
tively.
Studies of kidney eluates. The material eluted from the
kidneys of mercuric-chloride-treated rats contained only rat
IgG as determined by precipitation in agar and immunoelectro-
phoresis. When tested by indirect immunofluorescence, the
eluate stained normal rat kidney GBM with a 3+ intensity at a
1:5 dilution (with a protein content of 600 J.gIml) and with an
endpoint at 1:160 (19 igIml). On the other hand, antibodies to
GBM were still detected by ELISA at a dilution of 1:1000 (0.06
g!ml).
Discussion
When sera from mercuric-chloride-treated rats were tested
by ELISA, we observed positive reactions in 100% of the
animals. In contrast, only 45% were positive when tested by
indirect immunofluorescence on cryostat sections of rat kidney.
The titers of anti-GBM antibodies obtained by ELISA ranged
between 5 and 700, whereas those obtained in indirect immuno-
fluorescence were never above 20. Thus, ELISA proved to be
much more sensitive than indirect immunofluorescence. The
specificity of the reaction was clearly demonstrated by the fact
that sera from control rats showed minimal binding to the GBM
and by significant inhibition obtained when positive sera were
preincubated with GBM. On the other hand, preincubation of
the same sera with an unrelated antigen such as rat thyroglobu-
lin did not cause any inhibition of the anti-GBM reaction.
Antibodies to GBM eluted from kidneys of mercuric-chloride-
treated rats were similarly detected by ELISA. It was found
that as little as 0.06 g/ml antibody protein were easily detect-
able.
The binding of GBM to microtiter plates varies between
different brands and lot numbers. Other antigens of similar
composition, such as bacterial polysaccharides, also coat
ELISA plates in an irregular fashion [10—121. But, we have
noticed that once a satisfactory lot of microtiter plates is
identified and is used routinely, day-to-day reproducibility of
this ELISA is extremely satisfactory. In addition, preliminary
data indicate that collagenase-solubilized GBM [13, 141 retains
sufficient antigenic sites for use in this ELISA system. Collage-
nase solubilization appears to facilitate binding of the GBM to
microtiter plates more than urea solubilization does. Thus, the
problem of unpredictability in coating different lots of plates
may be solved by using the enzyme-solubilized GBM.
In conclusion, our study shows that ELISA may be used for
the detection of anti-GBM antibodies in rats treated with
mercuric chloride. With appropriate changes in reagents, this
test can be applied for the demonstration of anti-GBM antibod-
ies in sera from patients with Goodpasture's syndrome and
other human anti-basement membrane antibody-induced dis-
eases, as recently reported in a short abstract by Wheeler and
Sussman [15].
Reprint requests to Dr. P. E. Bigazzi, Department of Pathology,
University of Connecticut Health Center, Farminglon, Connecticut
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